Quantcast

Latest Bone tumor Stories

2012-04-04 09:22:50

Many children with the bone cancer, osteosarcoma, die after the tumor spreads to their lungs. In a critical step toward finding a way to stop metastasis, researchers at Georgetown Lombardi Comprehensive Cancer Center say they have discovered an agent that prevents this type of cancer from spreading to the lungs in mice with the disease. The new agent stops or inhibits "ezrin," a protein vital to the spread of osteosarcoma, say the researchers who presented their findings today at the...

2011-07-28 18:14:00

The International and American Associations for Dental Research have released in its Journal of Dental Research a study that investigated bone fluoride levels in individuals with osteosarcoma, which is a rare, primary malignant bone tumor that is more prevalent in males. Since there has been controversy as to whether there is an association between fluoride and risk for osteosarcoma, the purpose of this study, titled "An Assessment of Bone Fluoride and Osteosarcoma," was to determine if bone...

2011-05-05 15:02:32

In a rare and medically remarkable operation, a multi-disciplinary team of surgeons at the Ohio State University Comprehensive Cancer Center "“ Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC "“ James) removed the left leg, hip and pelvis of a cancer patient, and used the healthy, living bones from his amputated leg to completely rebuild the connection between his spine and remaining right pelvis to support a high-tech prosthetic leg. "This...

2010-10-04 22:52:13

Nationally recognized orthopedic oncologist presents new surgical techniques to preserve bone and soft tissue in bone cancers James C. Wittig, M.D. and colleagues will conduct a total of eight research presentations at the upcoming 96th Annual Clinical Congress of the American College of Surgeons and the 65th Annual Meeting of the American Society for Surgery of the Hand. Dr. Wittig, an orthopedic oncologist with extensive experience in performing limb-sparing surgeries, is Chief of the...

2010-10-04 12:27:00

HACKENSACK, N.J., Oct. 4 /PRNewswire/ -- James C. Wittig, M.D. and colleagues will conduct a total of eight research presentations at the upcoming 96th Annual Clinical Congress of the American College of Surgeons and the 65th Annual Meeting of the American Society for Surgery of the Hand. Dr. Wittig, an orthopedic oncologist with extensive experience in performing limb-sparing surgeries, is Chief of the Division of Skin and Sarcoma Cancer of the John Theurer Cancer Center at Hackensack...

2010-07-08 18:00:00

HIGH WYCOMBE, England, July 9, 2010 /PRNewswire/ -- - In a draft appraisal the National Institute for Health and Clinical Excellence (NICE) has refused to recommend the first treatment shown to improve survival in childhood bone cancer (osteosarcoma) in more than 20 years(1,2) - Data shows Mepact(R) (mifamurtide) reduces the risk of death by almost one third when added to standard chemotherapy treatment, compared with chemotherapy alone(3) -...

2010-03-16 09:38:49

Interventional radiologists pioneer potential treatment for cancer that has metastasized to soft tissues (such as ovarian cancer) and bones; seen as option for those who are not candidates for surgery Cryotherapy, an interventional radiology treatment to freeze cancer tumors, may become the treatment of the future for cancer that has metastasized in soft tissues (such as ovarian cancer) and in bone tumors. Such patients are often not candidates for surgery and would benefit from minimally...

2010-02-23 09:13:54

Dr. Tsz-Kwong Man, a researcher with the Texas Children's Cancer Center at Baylor College of Medicine, has a received a grant from the Liddy Shriver Sarcoma Initiative to study the function of a protein that may promote the spread of a common form of children's bone cancer called osteosarcoma. "This is a devastating cancer," said Man, principal investigator of the study. "Once the cancer spreads to other parts of the body, and it often does, it can be very aggressive and has poor survival...

2009-11-05 13:23:33

A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer. The study drug, Bortezomib, was found to be effective against bone cancer in human cancer cell studies and in mice. While key experiments were in animals, the cancer studied closely resembled the human form and the drug has already been proven to be safe in human...

2009-10-12 14:04:00

SAN MARINO, Calif., Oct. 12 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic. Administered as stand-alone therapy in late-stage cases of chemotherapy-resistant cancer, Rexin-G has once again accomplished what standard cancer treatments and even much-touted biologics have failed to do: that is, to bring...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related